Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Nuevolution AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Nuevolution AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Nuevolution AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Nuevolution AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Nuevolution AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nuevolution AB, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Nuevolution Raises US$13.7 Million Venture Financing Round 11
Partnerships 12
Nuevolution Enters into Co-Development Agreement with Almirall 12
Nuevolution Enters into Research Agreement with Amgen 13
Nuevolution Enters into Discovery Agreement with Janssen Biotech 14
Nuevolution Enters Into Agreement With Cancer Research Technology And Institute Of Cancer Research For Drug Discovery 15
Cancer Research Technology Enters Into Agreement With Nuevolution For Anti-Cancer Drug Molecule Discovery 17
Nuevolution Enters Into Agreement With Howard Hughes Medical Institute, Lexicon Pharma And Duke University For Drug Discovery 18
Licensing Agreements 19
Amgen Exercises Option for Licensing Agreement with Nuevolution 19
Janssen Biotech Enters into Licensing Agreement with Nuevolution 20
Nuevolution Enters Into Licensing Agreement With Novartis 21
Equity Offering 22
Nuevolution Raises USD290 Million in IPO of Shares 22
Nuevolution AB – Key Competitors 23
Nuevolution AB – Key Employees 24
Nuevolution AB – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
May 08, 2018: Nuevolution announces its results for the first quarter of 2018 and provides update on partnership discussions 26
Feb 08, 2018: Nuevolution announces its year-end report for 2017 and report for the three-month period ended 31 December 2017 27
Sep 06, 2017: Nuevolution announces its results for the fourth quarter and full year 2016/17 28
May 17, 2017: Nuevolution announces its results for the third quarter 2016/17 29
Corporate Communications 30
Apr 24, 2018: Nuevolution’s Board of Directors to Be Reduced From Six to Five Members 30
Jan 23, 2018: Nuevolution appoint Dr. Paul Scigalla as Chief Medical Officer on consultancy basis 31
Oct 30, 2017: Fredrik Arp is Proposed as Board Member in Nuevolution 32
Legal and Regulatory 33
Dec 08, 2017: The Danish Eastern High Court revokes the Maritime and Commercial High Court’s decision of 22 February 2016 in favour of Nuevolution’s request 33
Product News 34
08/22/2018: Nuevolution discloses the identity of its Cytokine X program being interleukin IL-17A and initiates promotion of its small molecule IL-17A inhibitor program targeting inflammatory diseases 34
May 17, 2018: Nuevolution announces the publication of a second scientific article from the collaboration with Nobel Laureate Dr. Robert J. Lefkowitz 35
Feb 14, 2017: Nuevolution Technology Progress: Nuevolution Scales its Compound Collection to 40 Trillion Using its Chemetics Drug Discovery Platform 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
Nuevolution AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Nuevolution AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Nuevolution AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Nuevolution AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Nuevolution AB, Deals By Therapy Area, 2012 to YTD 2018 9
Nuevolution AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nuevolution Raises US$13.7 Million Venture Financing Round 11
Nuevolution Enters into Co-Development Agreement with Almirall 12
Nuevolution Enters into Research Agreement with Amgen 13
Nuevolution Enters into Discovery Agreement with Janssen Biotech 14
Nuevolution Enters Into Agreement With Cancer Research Technology And Institute Of Cancer Research For Drug Discovery 15
Cancer Research Technology Enters Into Agreement With Nuevolution For Anti-Cancer Drug Molecule Discovery 17
Nuevolution Enters Into Agreement With Howard Hughes Medical Institute, Lexicon Pharma And Duke University For Drug Discovery 18
Amgen Exercises Option for Licensing Agreement with Nuevolution 19
Janssen Biotech Enters into Licensing Agreement with Nuevolution 20
Nuevolution Enters Into Licensing Agreement With Novartis 21
Nuevolution Raises USD290 Million in IPO of Shares 22
Nuevolution AB, Key Competitors 23
Nuevolution AB, Key Employees 24
Nuevolution AB, Subsidiaries 25
List of Figures
Nuevolution AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nuevolution AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nuevolution AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nuevolution AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nuevolution AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Nuevolution AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Nuevolution AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Nuevolution AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9